Anhui Huaren Health Pharmaceutical Management
Management criteria checks 4/4
Anhui Huaren Health Pharmaceutical's CEO is Jiale He, appointed in Jan 2014, has a tenure of 12.08 years. directly owns 50.12% of the company’s shares, worth CN¥3.97B. The average tenure of the management team and the board of directors is 10.8 years and 5.4 years respectively.
Key information
Jiale He
Chief executive officer
CN¥700.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.1yrs |
| CEO ownership | 50.1% |
| Management average tenure | 10.8yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
CEO
Jiale He (49 yo)
Mr. Jiale He is General Manager & Chairman of the Board of Anhui Huaren Health Pharmaceutical Co. Ltd. from January 18, 2014.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | 12.1yrs | CN¥700.00k | 50.12% CN¥ 4.0b | |
| CFO, Secretary & Accounting Supervisor | 7.8yrs | CN¥500.00k | no data | |
| Deputy GM & Director | 10.8yrs | CN¥612.80k | 6.89% CN¥ 545.9m | |
| Deputy GM & Director | 12.1yrs | CN¥608.90k | no data | |
| Deputy GM & Director | 1.8yrs | CN¥726.50k | no data |
Experienced Management: 301408's management team is seasoned and experienced (10.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | 12.1yrs | CN¥700.00k | 50.12% CN¥ 4.0b | |
| Deputy GM & Director | 10.8yrs | CN¥612.80k | 6.89% CN¥ 545.9m | |
| Deputy GM & Director | 12.1yrs | CN¥608.90k | no data | |
| Deputy GM & Director | 1.8yrs | CN¥726.50k | no data | |
| Director | 7.2yrs | no data | no data | |
| Non-Independent Director | 2.8yrs | no data | no data | |
| Supervisor | 5.4yrs | no data | no data | |
| Supervisor | 7.8yrs | no data | no data | |
| Independent Director | 1.8yrs | CN¥56.30k | no data | |
| Independent Director | 1.8yrs | CN¥56.30k | no data | |
| Independent Director | 1.8yrs | CN¥56.30k | no data |
Experienced Board: 301408's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/13 19:40 |
| End of Day Share Price | 2026/02/13 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Anhui Huaren Health Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.